Adrenocorticotrophic hormone ACTH ( DrugBank: ACTH )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 222 | Primary nephrotic syndrome | 1 |
222. Primary nephrotic syndrome
Clinical trials : 310 / Drugs : 295 - (DrugBank : 117) / Drug target genes : 63 - Drug target pathways : 194
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01093157 (ClinicalTrials.gov) | February 2010 | 24/3/2010 | A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy | A Dose-finding Pilot Study of ACTH (Adrenocorticotropic Hormone) on the Proteinuria and Serum Lipoprotein Profile in Patients With Idiopathic Membranous Nephropathy (MN) | Glomerulonephritis | Drug: Adrenocorticotrophic hormone ACTH | University Health Network, Toronto | Mallinckrodt | Completed | 18 Years | 72 Years | All | 10 | Phase 1/Phase 2 | Canada |